Search
Search Results
##search.searchResults.foundPlural##
-
How I treat acute and persistent sickle cell pain
1910PDF: 1112HTML: 482 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2004PDF: 758HTML: 3113 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1379PDF: 814HTML: 3117 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
934PDF: 510HTML: 191 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1446PDF: 1049HTML: 215 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13251PDF: 961HTML: 7287 -
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2240PDF: 930HTML: 299 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2765PDF: 1800HTML: 3663Pellagatti Fig 1: 210Pellagatti Fig. 2: 206 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
717PDF: 833PDF Supp. Files: 76HTML: 185 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1589PDF: 577HTML: 221 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4283PDF: 1368HTML: 2035 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1959PDF: 742HTML: 694 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
947PDF: 577HTML: 336 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1370PDF: 1301HTML: 94 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
3039PDF: 1839HTML: 233 -
Pseudo-differentiation syndrome
1339PDF: 656HTML: 10845Figure 1: peripheral blood showing myeloblasts with auer rods: 117Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 102Figure 3: CXR showing pulmonary infiltartes with consolidation: 136Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 109Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 117 -
The significance of purity: Leukaemias involving the erythroid lineage Erythroid lineage leukemia
796PDF: 418HTML: 282 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12329PDF: 1672HTML: 4164Cover letter: 196Figure 1: 202 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1508PDF: 934HTML: 220 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1228PDF: 976HTML: 209 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
866PDF: 472HTML: 123Suppl. Files: 308







